NeuroSense Therapeutics Ltd.
NRSN | NASDAQ
$1.99
-$0.14 (-6.57%)
At close: Oct 30, 2026, 4:00 PM ET
$1.99
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Net Income | -11.13M | -10.21M | -10.11M | -12.34M | -4.04M | -2.83M |
Depreciation & Amortization | 16K | 22K | 21K | 89K | 3K | 3K |
Stock-Based Compensation | 2.14M | 557K | 1.54M | 5.11M | 4.16M | 2.06M |
Other Working Capital | 1.71M | -482K | 933K | 291K | 493K | 51K |
Other Non-Cash Items | -46K | 277K | -1.71M | -1.19M | 791K | -2K |
Deferred Income Tax | n/a | n/a | n/a | n/a | -2.72M | 2K |
Change in Working Capital | 1.34M | -781K | 1.91M | 750K | 273K | 71K |
Operating Cash Flow | -7.67M | -10.14M | -8.35M | -7.59M | -1.54M | -695K |
Capital Expenditures | -8K | -3K | -29K | -70K | -17K | -9K |
Cash Acquisitions | n/a | n/a | 3K | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | -3.5M | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | 3.5M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 4K | -6K | 29K | n/a | n/a |
Investing Cash Flow | -8K | 1K | 3.47M | -3.54M | -17K | -9K |
Debt Repayment | n/a | n/a | -80K | -79K | 1.24M | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -121K | -391K | 80K | -96K | 800K | n/a |
Financial Cash Flow | 4.43M | 10.91M | 3.98M | 3.7M | 11.9M | 508K |
Net Cash Flow | -3.21M | 738K | -903K | -7.52M | 10.36M | -196K |
Free Cash Flow | -7.68M | -10.14M | -8.38M | -7.66M | -1.56M | -704K |
Adj. Free Cash Flow | -9.82M | -10.7M | -9.92M | -12.76M | -5.72M | -2.77M |
Maintenance CapEx | -8K | -3K | -21K | -70K | -3K | -3K |
Growth CapEx | n/a | n/a | -8K | n/a | -14K | -6K |
Owner Earnings | -7.68M | -10.14M | -8.38M | -7.66M | -1.54M | -698K |
Add to Watchlist
Select watchlists to add or remove NRSN